[go: up one dir, main page]

WO2009038092A1 - Agent antifatigue contenant de l'acide arachidonique en tant qu'ingrédient actif - Google Patents

Agent antifatigue contenant de l'acide arachidonique en tant qu'ingrédient actif Download PDF

Info

Publication number
WO2009038092A1
WO2009038092A1 PCT/JP2008/066769 JP2008066769W WO2009038092A1 WO 2009038092 A1 WO2009038092 A1 WO 2009038092A1 JP 2008066769 W JP2008066769 W JP 2008066769W WO 2009038092 A1 WO2009038092 A1 WO 2009038092A1
Authority
WO
WIPO (PCT)
Prior art keywords
arachidonic acid
fatigue agent
active ingredient
fatigue
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/066769
Other languages
English (en)
Japanese (ja)
Inventor
Daisuke Takemoto
Yoshiko Ono
Masanori Kontani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Suntory Ltd
Original Assignee
Suntory Holdings Ltd
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd, Suntory Ltd filed Critical Suntory Holdings Ltd
Publication of WO2009038092A1 publication Critical patent/WO2009038092A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention porte sur : un agent antifatigue qui est sans danger chez l'humain comme chez l'animal et qui peut par conséquent être ingéré en continu, et qui prévient et/ou traite efficacement la fatigue ; ainsi que sur une composition pharmaceutique contenant l'agent antifatigue. Sont spécifiquement décrits : un agent antifatigue contenant de l'acide arachidonique, un composé contenant de l'acide arachidonique en tant qu'acide gras constitutif ou un mélange de ceux-ci en tant qu'ingrédient actif ; et une composition pharmaceutique.
PCT/JP2008/066769 2007-09-19 2008-09-17 Agent antifatigue contenant de l'acide arachidonique en tant qu'ingrédient actif Ceased WO2009038092A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007243004A JP2009073747A (ja) 2007-09-19 2007-09-19 アラキドン酸を有効成分とする抗疲労剤
JP2007-243004 2007-09-19

Publications (1)

Publication Number Publication Date
WO2009038092A1 true WO2009038092A1 (fr) 2009-03-26

Family

ID=40467902

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/066769 Ceased WO2009038092A1 (fr) 2007-09-19 2008-09-17 Agent antifatigue contenant de l'acide arachidonique en tant qu'ingrédient actif

Country Status (3)

Country Link
JP (1) JP2009073747A (fr)
TW (1) TW200930358A (fr)
WO (1) WO2009038092A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05194244A (ja) * 1991-07-24 1993-08-03 Efamol Ltd 必須脂肪酸を含有する薬剤
JPH0759540A (ja) * 1993-08-26 1995-03-07 Tokiwa Yakuhin Kogyo Kk アラキドン酸含有健康食品

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05194244A (ja) * 1991-07-24 1993-08-03 Efamol Ltd 必須脂肪酸を含有する薬剤
JPH0759540A (ja) * 1993-08-26 1995-03-07 Tokiwa Yakuhin Kogyo Kk アラキドン酸含有健康食品

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JUNKO SHIMURA ET AL.: "Kaisan Dobutsuyu o Toyo shita Rat no Ketsueki ? Kesseichu no Shishitsu Sosei no Henka", JOURNAL OF VETERINARY MEDICINE, vol. 50, no. 11, 1997, pages 921 - 924 *
YOSHIKAZU OGAWA ET AL.: "Mansei Hiro Shokogun Kanja ni Okeru Fuhowa Shibosan no Taisha Ijo", JAPAN MEDICAL JOURNAL, no. 3557, 1992, pages 33 - 34 *

Also Published As

Publication number Publication date
TW200930358A (en) 2009-07-16
JP2009073747A (ja) 2009-04-09

Similar Documents

Publication Publication Date Title
WO2010001169A3 (fr) Composés chimiques 251
WO2011107749A3 (fr) Libération pulsatile de médicament
WO2011112229A3 (fr) Préparations d'agent thérapeutique pour une administration dans une lumière du tractus intestinal à l'aide d'un dispositif d'administration de médicament avalable
WO2011107755A3 (fr) Administration immédiate / retardée de médicament
WO2011118976A3 (fr) Composition pharmaceutique pour la prévention ou le traitement d'une stéatose hépatique non alcoolique et procédé pour la prévention ou le traitement de la stéatose hépatique non alcoolique utilisant celle-ci
MX348705B (es) Composiciones farmacéuticas y métodos de administración relacionados.
WO2008149802A1 (fr) Agent anti-fatigue et composition orale comprenant chacun de l'andrographolide en tant que principe actif
WO2006059234A3 (fr) Amides bicycliques comme inhibiteurs de kinases
WO2011061330A3 (fr) Utilisation d'agents rafraîchissants physiologiques et produits contenant de tels agents
WO2012087742A3 (fr) Procédés et compositions appropriés pour la gestion de la glycémie chez des animaux
WO2008093793A1 (fr) Agent pour soulager ou prévenir la xérostomie
WO2008126587A1 (fr) Agent anti-fatigue
WO2011151722A3 (fr) Méthodes et compositions de traitement pharmaceutique par voie orale
MY147647A (en) Imidazo [1,2-a] pyridine derivatives : preparation and pharmaceutical applications
UA101903C2 (ru) Лекарственное средство на основе дииндолилметана для лечения гиперпластических и воспалительных заболеваний
WO2008093075A3 (fr) Dérivés de 5,6,7,8-tétrahydroptéridine comme inhibiteurs de hsp90
WO2011054322A8 (fr) Mélange antifongique comportant l'organisme fongique pythium oligandrum
GB2456475A (en) Composition for the treatment of skin conditions
WO2008105088A1 (fr) Agent de traitement d'une lésion de la moelle épinière
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
WO2009003719A3 (fr) Dérivés d'indane-amine, leur préparation et leur utilisation comme médicaments
EP1938824A4 (fr) Médicaments, aliments et boissons ou aliments pour animaux contenant de la sphingomyéline
MX2013002649A (es) Agente terapeutico contra el dolor.
WO2009038090A1 (fr) Composition contenant un composant de sésamine et un composant d'acide arachidonique
HK1203394A1 (en) Ghrelin receptor agonists for the treatment of achlorhydria

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08832732

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08832732

Country of ref document: EP

Kind code of ref document: A1